logo
man in an outdoor settingwoman in suit coat in office setting smilingteal triangle graphic

Medicines

Innovation Focused
on Complex Diseases


Our Medicines

Alkermes’ technologies and discoveries have contributed to the development of medicines that have helped shape the treatment landscape in a range of disease areas. Our portfolio of proprietary commercial products includes medicines approved for the treatment of alcohol dependence, opioid dependence, schizophrenia, bipolar I disorder and narcolepsy. 


Proprietary U.S. Medicines


We are driven to develop innovative medicines that can help address the unmet needs of patients living with chronic neurological and psychiatric disorders. We proudly manufacture three of our proprietary products at our facility in Wilmington, Ohio.


Our proprietary U.S. medicines

Third-Party Medicines

Our proprietary technologies are incorporated into third-party medicines that are commercialized by other global pharmaceutical companies for people living with a range of serious diseases.
Learn more about third-party medicines that utilize our proprietary technologies.

U.S. medicines   EU medicines

Man in a conference room at Alkermesteal triangle graphic

Commitment to patients runs very deep at Alkermes. It starts when we discover new ideas in our labs, continues as we conduct clinical trials, make our medicines, educate stakeholders about unmet needs and support those who take our medicines.